HPCAL1 as a novel prognostic biomarker in acute myeloid leukemia and its correlation with immune infiltrates.

This analysis revealed no differences in the stromal score between the groups, although highly significant differences were found, where the HPCAL1 -high cohort presented higher immune and ESTIMATE scores but lower tumor purity scores (Fig. 2 A).

also in 132,142 other papers